Overall Score

Revenue Growth

Revenue growth is not evidenced in the provided fresh data, and the company’s low sales multiple (0.29x P/S, 0.56x EV/S) suggests the market is not pricing in strong long-term top-line expansion.

The business is still operating with thin profitability, which limits confidence that revenue growth will translate into durable 10-year value creation.

Profitability

Margins remain weak, with gross margin at 5.6% and EBIT margin at -0.7%, indicating limited operating leverage.

Returns are still negative across ROA (-1.1%), ROE (-2.2%), and ROIC (-1.4%), showing the company is not yet compounding capital effectively.

Financial Health

Liquidity is acceptable but not strong, with a current ratio of 1.28 and quick ratio of 0.70.

Leverage remains elevated at 8.0x net debt/EBITDA, and interest coverage is negative at -2.3x, which keeps balance-sheet risk high.

Cash Flow Generation

Free cash flow remains negative on a TTM basis, with FCF yield at -5.6% and FCF/EBITDA still deeply negative.

Capex continues to exceed operating cash flow (capex/OCF 1.30x), suggesting cash generation is not yet self-funding.

Valuation

Valuation is inexpensive on sales and book value, with P/S at 0.29x and P/B at 0.58x.

However, the discount is offset by negative earnings and free cash flow, so the low multiple is not yet a clear value signal.